|
Traits
|
1722
|
48 (3%)
|
19 (1%)
|
15 (1%)
|
|
SNPs
|
48,881
|
64 (0.1%)
|
26 (0%)
|
15 (0%)
|
|
Age at menopause
|
84
|
1 (1%)
|
1 (1%)
|
0 (0%)
|
|
Alzheimer's disease (late onset)
|
55
|
1 (2%)
|
1 (2%)
|
1 (2%)
|
|
Asthma
|
206
|
2 (1%)
|
0 (0%)
|
1 (0%)
|
|
Asthma or allergic disease (pleiotropy)
|
36
|
1 (3%)
|
0 (0%)
|
0 (0%)
|
|
Blood metabolite levels
|
195
|
1 (1%)
|
1 (1%)
|
0 (0%)
|
|
Blood protein levels
|
2772
|
10 (0%)
|
7 (0%)
|
2 (0%)
|
|
Blood urea nitrogen levels
|
111
|
1 (1%)
|
0 (0%)
|
0 (0%)
|
|
Childhood ear infection
|
19
|
2 (11%)
|
2 (11%)
|
2 (11%)
|
|
Chronic lymphocytic leukemia
|
73
|
1 (1%)
|
0 (0%)
|
1 (1%)
|
|
Circulating chemerin levels
|
4
|
4 (100%)
|
0 (0%)
|
0 (0%)
|
|
Colorectal cancer
|
116
|
3 (3%)
|
1 (1%)
|
1 (1%)
|
|
Colorectal cancer or advanced adenoma
|
94
|
1 (1%)
|
0 (0%)
|
0 (0%)
|
|
Drug-induced liver injury (amoxicillin-clavulanate)
|
2
|
1 (50%)
|
1 (50%)
|
0 (0%)
|
|
Educational attainment (MTAG)
|
1320
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Eosinophil percentage of granulocytes
|
179
|
1 (1%)
|
1 (1%)
|
1 (1%)
|
|
Hair color
|
449
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Heart rate response to exercise
|
20
|
1 (5%)
|
1 (5%)
|
1 (5%)
|
|
Heel bone mineral density
|
2262
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
High density lipoprotein cholesterol levels
|
306
|
2 (1%)
|
0 (0%)
|
0 (0%)
|
|
Highest math class taken (MTAG)
|
1084
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Intraocular pressure
|
512
|
2 (0%)
|
0 (0%)
|
0 (0%)
|
|
Liver enzyme levels
|
9
|
1 (11%)
|
0 (0%)
|
0 (0%)
|
|
Liver enzyme levels (gamma-glutamyl transferase)
|
26
|
2 (8%)
|
2 (8%)
|
1 (4%)
|
|
Lumiracoxib-related liver injury
|
1
|
1 (100%)
|
0 (0%)
|
0 (0%)
|
|
Mean platelet volume
|
323
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Medication use (adrenergics, inhalants)
|
55
|
1 (2%)
|
0 (0%)
|
0 (0%)
|
|
Menopause (age at onset)
|
63
|
1 (2%)
|
1 (2%)
|
0 (0%)
|
|
Metabolite levels
|
66
|
2 (3%)
|
0 (0%)
|
0 (0%)
|
|
Metabolite levels (small molecules and protein measures)
|
32
|
1 (3%)
|
0 (0%)
|
0 (0%)
|
|
Multiple sclerosis
|
158
|
1 (1%)
|
0 (0%)
|
0 (0%)
|
|
Multiple sclerosis (OCB status)
|
6
|
2 (33%)
|
1 (17%)
|
1 (17%)
|
|
Oligoclonal band status in multiple sclerosis
|
1
|
1 (100%)
|
1 (100%)
|
1 (100%)
|
|
Plasma homocysteine levels (post-methionine load test)
|
5
|
1 (20%)
|
1 (20%)
|
0 (0%)
|
|
Platelet count
|
323
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Plateletcrit
|
258
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Pulse pressure
|
747
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Red cell distribution width
|
821
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
S-phenylmercapturic acid levels in smokers
|
1
|
1 (100%)
|
0 (0%)
|
0 (0%)
|
|
Serum metabolite levels
|
76
|
1 (1%)
|
1 (1%)
|
0 (0%)
|
|
Systemic lupus erythematosus
|
195
|
1 (1%)
|
1 (1%)
|
1 (1%)
|
|
Systolic blood pressure
|
1393
|
1 (0%)
|
0 (0%)
|
0 (0%)
|
|
Triglyceride levels in current drinkers
|
39
|
1 (3%)
|
0 (0%)
|
0 (0%)
|
|
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction
|
55
|
1 (2%)
|
0 (0%)
|
0 (0%)
|
|
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction
|
55
|
1 (2%)
|
0 (0%)
|
0 (0%)
|
|
Type 1 diabetes
|
87
|
1 (1%)
|
0 (0%)
|
1 (1%)
|
|
Type 2 diabetes
|
352
|
1 (0%)
|
1 (0%)
|
1 (0%)
|
|
Urinary 1,3-butadiene metabolite levels in smokers
|
2
|
2 (100%)
|
1 (50%)
|
1 (50%)
|
|
White blood cell count
|
854
|
2 (0%)
|
1 (0%)
|
0 (0%)
|
